Cheng Huang

3PUBLICATIONS

42CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 15, 2025

Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Feb 11, 2025

Metabolic parameter of baseline 18 F-FDG PET/CT with PINK models improve the prediction of treatment outcome in extranodal NK/T-cell lymphoma treated with P-GEMOX chemotherapy.

Cheng Huang, Yi Li, Haixia He

|Feb 06, 2025

High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Yan Gao, Liqin Ping, Changguo Shan

Pageof 1

Frequent Collaborators

2 joint publications

Yan Gao

2 joint publications

Haixia He

2 joint publications

Huiqiang Huang

2 joint publications

Xiaoxiao Wang

1 joint publications

Liqin Ping

1 joint publications

Changguo Shan

1 joint publications

Jing Tan

1 joint publications

Zhiming Li

1 joint publications

Hui Zhou

1 joint publications

Linbo Cai

Frequent Collaborators

2 joint publications

Yan Gao

2 joint publications

Haixia He

2 joint publications

Huiqiang Huang

2 joint publications

Xiaoxiao Wang